Therapeutics and Clinical Risk Management

Hughes, M., & Lentzsch, S. (2023). Safety and Efficacy of Subcutaneous Daratumumab in Systemic AL Amyloidosis. Therapeutics and Clinical Risk Management, Volume 19, 1063–1074. https://doi.org/10.2147/tcrm.s325859

Publication Date

2023-12-01

Columbia Affiliation

Vagelos College of Physicians and Surgeons; Department of Medicine; Division of Hematology/Oncology

View

OpenAlex Record

PubMed Record

Web of Science Record

More Information